BGI Genomics Co., Ltd. (SHE:300676)

China flag China · Delayed Price · Currency is CNY
51.06
+1.08 (2.16%)
Sep 5, 2025, 3:04 PM CST
2.16%
Market Cap19.60B
Revenue (ttm)3.63B
Net Income (ttm)-915.11M
Shares Out383.85M
EPS (ttm)-2.23
PE Ration/a
Forward PE779.91
Dividend0.10 (0.20%)
Ex-Dividend DateJul 4, 2024
Volume6,947,920
Average Volume9,556,698
Open54.46
Previous Close49.98
Day's Range49.27 - 54.46
52-Week Range33.75 - 70.30
Beta0.74
RSI43.89
Earnings DateAug 23, 2025

About BGI Genomics

BGI Genomics Co., Ltd. provides genomic sequencing and proteomic services in China and internationally. The company offers solutions to various applications, such as basic research covering human, plant, animal, and microbial species; clinical research in human health; genetic testing and screening; drug discovery and development; and agriculture and biodiversity preservation and sustainability. It provides DNA, RNA, and customized sequencing solutions; and mass spec services, as well as COVID-19 PCR test kits and COVID lab solutions. In additi... [Read more]

Sector Healthcare
Founded 1999
Employees 3,702
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300676
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.